Synthetic Biology Patent Application Trends 2024

Synthetic Biology patent applications in 2024

Top Technology Areas in Synthetic Biology

Top CPC Codes

• C12P19/12 (No explanation available)
  • Count: 4 patents
  • Example: 20240200021. CELLULAR PRODUCTION OF SIALYLATED DI- AND/OR OLIGOSACCHARIDES simplified abstract (INBIOSE N.V.)
• C12N9/1085 (No explanation available)
  • Count: 3 patents
  • Example: 20240101614. CHAPERONES FOR HETEROLOGOUS EXPRESSION SYSTEMS simplified abstract (Inscripta, Inc.)
• C12N2310/20 (No explanation available)
  • Count: 3 patents
  • Example: 20240101989. NUCLEASE-MEDIATED GENOME EDITING simplified abstract (Wageningen Universiteit)
• C12N1/205 (No explanation available)
  • Count: 3 patents
  • Example: 20240200021. CELLULAR PRODUCTION OF SIALYLATED DI- AND/OR OLIGOSACCHARIDES simplified abstract (INBIOSE N.V.)
• C12N9/1081 (No explanation available)
  • Count: 3 patents
  • Example: 20240200021. CELLULAR PRODUCTION OF SIALYLATED DI- AND/OR OLIGOSACCHARIDES simplified abstract (INBIOSE N.V.)
• C12N9/1051 (No explanation available)
  • Count: 3 patents
  • Example: 20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL simplified abstract (INBIOSE N.V.)
• C12N15/113 (No explanation available)
  • Count: 2 patents
  • Example: 20240124877. RNA CLEAVAGE-INDUCED TRANSCRIPT STABILIZER AND USES THEREOF simplified abstract (Massachusetts Institute of Technology)
• C12N2310/14 (No explanation available)
  • Count: 2 patents
  • Example: 20240124877. RNA CLEAVAGE-INDUCED TRANSCRIPT STABILIZER AND USES THEREOF simplified abstract (Massachusetts Institute of Technology)
• C07K14/415 (No explanation available)
  • Count: 2 patents
  • Example: 20240101614. CHAPERONES FOR HETEROLOGOUS EXPRESSION SYSTEMS simplified abstract (Inscripta, Inc.)
• C12N9/22 (No explanation available)
  • Count: 2 patents
  • Example: 20240101989. NUCLEASE-MEDIATED GENOME EDITING simplified abstract (Wageningen Universiteit)

Top Companies in Synthetic Biology

INBIOSE N.V.

• Number of Synthetic Biology patents: 5
• Top CPC codes:
  • C12P19/12 (No explanation available): 4 patents
  • C12N1/205 (No explanation available): 3 patents
  • C12N9/1081 (No explanation available): 3 patents
• Recent patents:
  • 20240035004. VARIANT SUCROSE PERMEASE POLYPEPTIDES simplified abstract (INBIOSE N.V.) (20240201)
  • 20240191270. FERMENTATIVE PRODUCTION simplified abstract (INBIOSE N.V.) (20240613)
  • 20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS simplified abstract (INBIOSE N.V.) (20240314)

Massachusetts Institute of Technology

• Number of Synthetic Biology patents: 2
• Top CPC codes:
  • C12N15/113 (No explanation available): 1 patents
  • A61K48/0066 (No explanation available): 1 patents
  • C12N15/63 (No explanation available): 1 patents
• Recent patents:
  • 20240124877. RNA CLEAVAGE-INDUCED TRANSCRIPT STABILIZER AND USES THEREOF simplified abstract (Massachusetts Institute of Technology) (20240418)
  • 20240067957. AUTOCATALYTIC BASE EDITING FOR RNA-RESPONSIVE TRANSLATIONAL CONTROL simplified abstract (Massachusetts Institute of Technology) (20240229)

Inscripta, Inc.

• Number of Synthetic Biology patents: 1
• Top CPC codes:
  • C07K14/415 (No explanation available): 1 patents
  • C12N9/1085 (No explanation available): 1 patents
• Recent patents:
  • 20240101614. CHAPERONES FOR HETEROLOGOUS EXPRESSION SYSTEMS simplified abstract (Inscripta, Inc.) (20240328)

Wageningen Universiteit

• Number of Synthetic Biology patents: 1
• Top CPC codes:
  • C12N9/22 (No explanation available): 1 patents
  • C12N15/11 (No explanation available): 1 patents
  • C07K2319/09 (No explanation available): 1 patents
• Recent patents:
  • 20240101989. NUCLEASE-MEDIATED GENOME EDITING simplified abstract (Wageningen Universiteit) (20240328)

Jiangnan University

• Number of Synthetic Biology patents: 1
• Top CPC codes:
  • C12P7/02 (No explanation available): 1 patents
  • C12N9/1085 (No explanation available): 1 patents
  • C12N9/88 (No explanation available): 1 patents
• Recent patents:
  • 20240117387. P450 Cytochrome Enzyme for Andrographolide Synthesis and Its Application simplified abstract (Jiangnan University) (20240411)

ETH ZÜRICH

• Number of Synthetic Biology patents: 1
• Top CPC codes:
  • C12N15/113 (No explanation available): 1 patents
  • C12N15/86 (No explanation available): 1 patents
  • C12N2310/14 (No explanation available): 1 patents
• Recent patents:
  • 20240209357. DNA CONSTRUCTS COMPRISING ALTERNATIVE PROMOTERS simplified abstract (ETH ZÜRICH) (20240627)

THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY

• Number of Synthetic Biology patents: 1
• Top CPC codes:
  • C12M41/00 (No explanation available): 1 patents
  • C12M27/16 (No explanation available): 1 patents
• Recent patents:
  • 20240052285. IMAGING-ENABLED BIOREACTOR FOR IN VITRO CULTIVATION AND BIOENGINEERING OF ISOLATED AIRWAY TISSUE simplified abstract (THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY) (20240215)

COLORADO STATE UNIVERSITY RESEARCH FOUNDATION

• Number of Synthetic Biology patents: 1
• Top CPC codes:
  • C12N15/8259 (No explanation available): 1 patents
  • C02F3/327 (No explanation available): 1 patents
  • C07K14/415 (No explanation available): 1 patents
• Recent patents:
  • 20240060080. SYNTHETIC DESALINATION GENETIC CIRCUIT IN PLANTS simplified abstract (COLORADO STATE UNIVERSITY RESEARCH FOUNDATION) (20240222)

Duke University

• Number of Synthetic Biology patents: 1
• Top CPC codes:
  • C12P7/42 (No explanation available): 1 patents
  • C12N9/0006 (No explanation available): 1 patents
  • C12N9/0008 (No explanation available): 1 patents
• Recent patents:
  • 20240035052. COMPOSITIONS AND METHODS FOR METABOLIC CONTROL OF A BIOFERMENTATION PROCESS WITH SYNTHETIC METABOLIC VALVES simplified abstract (Duke University) (20240201)

Eligo Biosciecne

• Number of Synthetic Biology patents: 1
• Top CPC codes:
  • C12N7/00 (No explanation available): 1 patents
  • C12N9/22 (No explanation available): 1 patents
  • C12N15/102 (No explanation available): 1 patents
• Recent patents:
  • 20240218335. TRANSCRIPTIONAL CONTROL IN PROKARYOTIC CELLS USING DNA-BINDING REPRESSORS simplified abstract (Eligo Biosciecne) (20240704)

New Companies in Synthetic Biology (Last Month)

800px

No new companies detected in the last month.

Emerging Technology Areas in Synthetic Biology

• C12N15/902 (No explanation available)
  • Count: 1 patents
  • Example: 20240026466. CELL-BASED DNA SENSORS AND METHODS OF USING SAME simplified abstract (Wisconsin Alumni Research Foundation)
• C12Q1/6897 (No explanation available)
  • Count: 1 patents
  • Example: 20240026466. CELL-BASED DNA SENSORS AND METHODS OF USING SAME simplified abstract (Wisconsin Alumni Research Foundation)
• C12Q1/689 (No explanation available)
  • Count: 1 patents
  • Example: 20240026466. CELL-BASED DNA SENSORS AND METHODS OF USING SAME simplified abstract (Wisconsin Alumni Research Foundation)
• C12N15/87 (No explanation available)
  • Count: 1 patents
  • Example: 20240218335. TRANSCRIPTIONAL CONTROL IN PROKARYOTIC CELLS USING DNA-BINDING REPRESSORS simplified abstract (Eligo Biosciecne)
• C12N15/102 (No explanation available)
  • Count: 1 patents
  • Example: 20240218335. TRANSCRIPTIONAL CONTROL IN PROKARYOTIC CELLS USING DNA-BINDING REPRESSORS simplified abstract (Eligo Biosciecne)
• C12N7/00 (No explanation available)
  • Count: 1 patents
  • Example: 20240218335. TRANSCRIPTIONAL CONTROL IN PROKARYOTIC CELLS USING DNA-BINDING REPRESSORS simplified abstract (Eligo Biosciecne)
• C12Y206/01016 (No explanation available)
  • Count: 1 patents
  • Example: 20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS simplified abstract (INBIOSE N.V.)
• C12Y204/99003 (No explanation available)
  • Count: 1 patents
  • Example: 20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS simplified abstract (INBIOSE N.V.)
• C12Y204/01222 (No explanation available)
  • Count: 1 patents
  • Example: 20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS simplified abstract (INBIOSE N.V.)
• C12N9/1096 (No explanation available)
  • Count: 1 patents
  • Example: 20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS simplified abstract (INBIOSE N.V.)

Top Companies in Emerging Synthetic Biology Technologies

• INBIOSE N.V.: 4 patents
• Eligo Biosciecne: 3 patents
• Wisconsin Alumni Research Foundation: 3 patents